Status
Conditions
Treatments
About
Efficacy and safety of MACUGEN in patients suffering from neovascular age-related macular degeneration in routine clinical practice at least as good as demonstrated in randomized multicenter clinical trials.
Full description
Eligible patients in routine clinical practice
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
adults with neovascular age-related macula degeneration
Exclusion criteria
according to SmPC
86 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal